001     155979
005     20240328115554.0
024 7 _ |a 10.3390/brainsci11060748
|2 doi
024 7 _ |a pmid:34200087
|2 pmid
024 7 _ |a pmc:PMC8228206
|2 pmc
037 _ _ |a DZNE-2021-01111
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Schischlevskij, Pavel
|b 0
245 _ _ |a Informal Caregiving in Amyotrophic Lateral Sclerosis (ALS): A High Caregiver Burden and Drastic Consequences on Caregivers' Lives.
260 _ _ |a Basel
|c 2021
|b MDPI AG
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1711617105_27784
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease that causes progressive autonomy loss and need for care. This does not only affect patients themselves, but also the patients' informal caregivers (CGs) in their health, personal and professional lives. The big efforts of this multi-center study were not only to evaluate the caregivers' burden and to identify its predictors, but it also should provide a specific understanding of the needs of ALS patients' CGs and fill the gap of knowledge on their personal and work lives. Using standardized questionnaires, primary data from patients and their main informal CGs (n = 249) were collected. Patients' functional status and disease severity were evaluated using the Barthel Index, the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) and the King's Stages for ALS. The caregivers' burden was recorded by the Zarit Burden Interview (ZBI). Comorbid anxiety and depression of caregivers were assessed by the Hospital Anxiety and Depression Scale. Additionally, the EuroQol Five Dimension Five Level Scale evaluated their health-related quality of life. The caregivers' burden was high (mean ZBI = 26/88, 0 = no burden, ≥24 = highly burdened) and correlated with patients' functional status (rp = -0.555, p < 0.001, n = 242). It was influenced by the CGs' own mental health issues due to caregiving (+11.36, 95% CI [6.84; 15.87], p < 0.001), patients' wheelchair dependency (+9.30, 95% CI [5.94; 12.66], p < 0.001) and was interrelated with the CGs' depression (rp = 0.627, p < 0.001, n = 234), anxiety (rp = 0.550, p < 0.001, n = 234), and poorer physical condition (rp = -0.362, p < 0.001, n = 237). Moreover, female CGs showed symptoms of anxiety more often, which also correlated with the patients' impairment in daily routine (rs = -0.280, p < 0.001, n = 169). As increasing disease severity, along with decreasing autonomy, was the main predictor of caregiver burden and showed to create relevant (negative) implications on CGs' lives, patient care and supportive therapies should address this issue. Moreover, in order to preserve the mental and physical health of the CGs, new concepts of care have to focus on both, on not only patients but also their CGs and gender-associated specific issues. As caregiving in ALS also significantly influences the socioeconomic status by restrictions in CGs' work lives and income, and the main reported needs being lack of psychological support and a high bureaucracy, the situation of CGs needs more attention. Apart from their own multi-disciplinary medical and psychological care, more support in care and patient management issues is required.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a amyotrophic lateral sclerosis (ALS)
|2 Other
650 _ 7 |a anxiety
|2 Other
650 _ 7 |a caregiver burden
|2 Other
650 _ 7 |a decreasing autonomy
|2 Other
650 _ 7 |a depression
|2 Other
650 _ 7 |a functional status
|2 Other
650 _ 7 |a health-related quality of life
|2 Other
650 _ 7 |a informal caregiving
|2 Other
650 _ 7 |a psychological support
|2 Other
650 _ 7 |a socioeconomic status
|2 Other
700 1 _ |a Cordts, Isabell
|b 1
700 1 _ |a Günther, René
|0 P:(DE-2719)2811849
|b 2
|u dzne
700 1 _ |a Stolte, Benjamin
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Zeller, Daniel
|b 4
700 1 _ |a Schröter, Carsten
|b 5
700 1 _ |a Weyen, Ute
|b 6
700 1 _ |a Regensburger, Martin
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Wolf, Joachim
|b 8
700 1 _ |a Schneider, Ilka
|b 9
700 1 _ |a Hermann, Andreas
|0 P:(DE-2719)2811732
|b 10
|u dzne
700 1 _ |a Metelmann, Moritz
|b 11
700 1 _ |a Kohl, Zacharias
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Linker, Ralf A
|b 13
700 1 _ |a Koch, Jan Christoph
|b 14
700 1 _ |a Stendel, Claudia
|0 P:(DE-2719)2812141
|b 15
|u dzne
700 1 _ |a Müschen, Lars H
|b 16
700 1 _ |a Osmanovic, Alma
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Binz, Camilla
|b 18
700 1 _ |a Klopstock, Thomas
|0 P:(DE-2719)2810704
|b 19
|u dzne
700 1 _ |a Dorst, Johannes
|b 20
700 1 _ |a Ludolph, Albert
|0 P:(DE-2719)2812633
|b 21
|u dzne
700 1 _ |a Boentert, Matthias
|0 P:(DE-HGF)0
|b 22
700 1 _ |a Hagenacker, Tim
|0 P:(DE-HGF)0
|b 23
700 1 _ |a Deschauer, Marcus
|b 24
700 1 _ |a Lingor, Paul
|0 P:(DE-2719)2812561
|b 25
|u dzne
700 1 _ |a Petri, Susanne
|b 26
700 1 _ |a Schreiber-Katz, Olivia
|0 P:(DE-HGF)0
|b 27
770 _ _ |a Caregiver Burden in Movement Disorders and Neurodegenerative Diseases
773 _ _ |a 10.3390/brainsci11060748
|g Vol. 11, no. 6, p. 748 -
|0 PERI:(DE-600)2651993-8
|n 6
|p 748
|t Brain Sciences
|v 11
|y 2021
|x 2076-3425
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/155979/files/DZNE-2021-01111.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/155979/files/DZNE-2021-01111.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:155979
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2811849
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2811732
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 15
|6 P:(DE-2719)2812141
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 19
|6 P:(DE-2719)2810704
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)2812633
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 25
|6 P:(DE-2719)2812561
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-03-30
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2020-09-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-03-30
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BRAIN SCI : 2021
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2022-01-07T14:19:48Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2020-09-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2022-01-07T14:19:48Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-03-30
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-03-30
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-03-30
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-03-30
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2020-09-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-09-15
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-03-30
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2020-09-15
920 1 _ |0 I:(DE-2719)1110002
|k AG Höglinger 1
|l Translational Neurodegeneration
|x 0
920 1 _ |0 I:(DE-2719)1111015
|k Clinical Research (Munich)
|l Clinical Research (Munich)
|x 1
920 1 _ |0 I:(DE-2719)5000077
|k Clinical Study Center Ulm
|l Clinical Study Center Ulm
|x 2
920 1 _ |0 I:(DE-2719)1510100
|k AG Teipel
|l Clinical Dementia Research (Rostock /Greifswald)
|x 3
920 1 _ |0 I:(DE-2719)1710012
|k AG Falkenburger
|l Translational Parkinson Research
|x 4
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1110002
980 _ _ |a I:(DE-2719)1111015
980 _ _ |a I:(DE-2719)5000077
980 _ _ |a I:(DE-2719)1510100
980 _ _ |a I:(DE-2719)1710012
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21